Drug design and development

Drug design and development is a multifaceted process that involves the identification of potential drug candidates, optimization of their properties for therapeutic efficacy and safety, and rigorous evaluation through preclinical and clinical studies before regulatory approval and market introduction. Here are the key steps and considerations involved in drug design and development:

  • Target Identification and Validation
  • Lead Discovery
  • Lead Optimization
  • Preclinical Testing

    Related Conference of Drug design and development

    July 25-26, 2024

    34th Annual European Pharma Congress

    Frankfurt, Germany
    August 06-07, 2024

    27th World Congress on Nursing, Pharmacology and Healthcare

    Aix-en-Provence, France
    August 28-29, 2024

    4th International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    October 31-01, 2024

    37th World Congress on Pharmacology

    Amsterdam, Netherlands
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE
    April 14-15, 2025

    18th European Biosimilars Congress

    Aix-en-Provence, France

    Drug design and development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in